Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-23-014792
Filing Date
2023-04-26
Accepted
2023-04-26 16:07:07
Documents
6
Period of Report
2023-06-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A rphm_2023_proxy.htm DEF 14A 1177899
2 GRAPHIC img16486698_0.jpg GRAPHIC 56290
3 GRAPHIC img16486698_1.jpg GRAPHIC 8106
4 GRAPHIC img16486698_2.jpg GRAPHIC 8106
5 GRAPHIC img16486698_3.jpg GRAPHIC 551821
6 GRAPHIC img16486698_4.jpg GRAPHIC 314872
  Complete submission text file 0000950170-23-014792.txt   2473023
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40315 | Film No.: 23849743
SIC: 2834 Pharmaceutical Preparations